[1] WaqasM,KhanI,ShamimMS, 2017.Role of 5-ALA in improving extent of tumor resection in patients with glioblastoma multiforme,J Pak Med Assoc 67 1630 -2
[2] KhanI,WaqasM,ShamimMS, 2017.Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme,J Pak Med Assoc 67 816 -7
[3] BinabajMM,BahramiA,ShahidSalesS,JoodiM,Joudi MashhadM,HassanianSM, 2018.The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials,J Cell Physiol 233 378 -86
[4] ThonN,EigenbrodS,Grasbon-FrodlEM,LutzJ,KrethS,PopperlG, 2011.Predominant influence of MGMT methylation in nonresectable glioblastoma after radiotherapy plus temozolomide,J NeurolNeurosurg Psychiatry 82 441 -
[5] EstellerM,HamiltonSR,BurgerPC,BaylinSB,HermanJG, 1999.Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia,Cancer Research 59 793 -7
[6] BobolaMS,BergerMS,SilberJR, 1995.Contribution of O6- methylguanine-DNA methyltransferase to resistance to 1, 3-(2- chloroethyl)-1-nitrosourea in human brain tumor-derived cell lines,Molecular Carcinogenesis 13 81 -8
[7] HegiME,DiserensAC,GorliaT,HamouMF,de TriboletN,WellerM, 2005.MGMT gene silencing and benefit from temozolomide in glioblastoma,N Engl J Med 352 997 -1003
[8] KimBS,KongDS,SeolHJ,NamDH,LeeJI, 2017.MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma,Journal of Neuro-Oncology 133 615 -22
[9] Lechapt-ZalcmanE,LevalletG,DuguéAE,VitalA,DieboldMD,MeneiP, 2012.-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide,Cancer 118 4545 -54
[10] ChristiansA,HartmannC,BennerA,MeyerJ,von DeimlingA,WellerM, 2012.Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma,PLoS ONE 7 e33449 -
[11] MinnitiG,SalvatiM,ArcellaA,ButtarelliF,D'EliaA,LanzettaG, 2011.Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide,J Neurooncol 102 311 -6
[12] 2015.Molecular biology in pediatric high-grade glioma: Impact on prognosis and treatment,Biomed Res Int 10 -
[13] MengW,JiangY, 2017.Is the prognostic significance of O6- methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis,Cancer Manag Res 9 411 -25
[14] YangH,WeiD,YangK,TangW,LuoY,ZhangJ, 2014.The prognosis of MGMT promoter methylation in glioblastoma patients of different race: a meta-analysis,Neurochem Res 39 2277 -87
[15] 2018.,World Neurosurg 2018; April 01 e342 -e347